|
|||||
|
|
Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries |
|
| Authors: | Moots Robert J Ostor Andrew J K Loft Anne G R Järvinen Pentti Larsson Per Ekelund Mats Reynolds Alan Kielar Danuta Lindkvist Rose-Marie Qvitzau Susanne |
| Institution: | Institute for Chronic Diseases and Ageing, University of Liverpool, Liverpool, UK. r.j.moots@liverpool.ac.uk |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |